Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BM.2.3SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BM.2.3SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BM.2.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BM.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.2.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.2.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CW.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
CW.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
CW.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CW.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
CW.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CW.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CW.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.42ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-2052.38South Korea
BA.5.2.42ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-301.668South Korea
BA.5.2.42SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.2.42SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.5.2.42EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.42NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.42NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAY.3ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
XAY.3ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XAY.3SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XAY.3SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XAY.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XAY.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAY.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.3.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
CH.3.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
CH.3.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CH.3.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
CH.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.3.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.46ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
XBB.1.46ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XBB.1.46SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBB.1.46SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XBB.1.46EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.46NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.46NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBC.1.1.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-2052.38South Korea
XBC.1.1.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XBC.1.1.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBC.1.1.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used